|
| | Publication Year | Title | Author(s) |
| 1 | Aug-2016 | A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma. | Brandes, Alba A; Carpentier, Antoine F; Kesari, Santosh; Sepulveda-Sanchez, Juan M; Wheeler, Helen R; Chinot, Olivier; Cher, Lawrence M ; Steinbach, Joachim P; Capper, David; Specenier, Pol; Rodon, Jordi; Cleverly, Ann; Smith, Claire; Gueorguieva, Ivelina; Miles, Colin; Guba, Susan C; Desaiah, Durisala; Lahn, Michael M; Wick, Wolfgang |
| 2 | Oct-2018 | A single-institution prospective evaluation of a neuro-oncology multidisciplinary team meeting. | Ameratunga, Malaka; Miller, Dorothea; Ng, Wayne; Wada, Morikatsu ; Gonzalvo, Augusto ; Cher, Lawrence M ; Gan, Hui K |
| 3 | Aug-2022 | Adult medulloblastoma in an Australian population. | Parakh, Sagun ; Davies, Amy; Westcott, Kerryn; Roos, Daniel; Abou-Hamden, Amal; Ahern, Elizabeth; Lau, Peter K H; Cheruvu, Sowmya; Pranavan, Ganesalingam; Pullar, Andrew; Lynam, James; Gzell, Cecelia; Whittle, James R; Cain, Sarah; Inglis, Po-Ling; Harrup, Rosemary; Anazodo, Antoinette; Hovey, Elizabeth; Cher, Lawrence M ; Gan, Hui K |
| 4 | 13-Nov-2023 | Antibody drug conjugates for glioblastoma: current progress toward clinical use. | Gan, Hui K ; Parakh, Sagun ; Osellame, Laura D; Cher, Lawrence M ; Uccellini, Anthony; Hafeez, Umbreen ; Menon, Siddharth; Scott, Andrew M |
| 5 | 6-May-2017 | Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine. | Capper, David; von Deimling, Andreas; Brandes, Alba A; Carpentier, Antoine F; Kesari, Santosh; Sepulveda-Sanchez, Juan M; Wheeler, Helen R; Chinot, Olivier; Cher, Lawrence M ; Steinbach, Joachim P; Specenier, Pol; Rodon, Jordi; Cleverly, Ann; Smith, Claire; Gueorguieva, Ivelina; Miles, Colin; Guba, Susan C; Desaiah, Durisala; Estrem, Shawn T; Lahn, Michael M; Wick, Wolfgang |
| 6 | Dec-2019 | Biomarkers and smart intracranial devices for the diagnosis, treatment, and monitoring of high-grade gliomas: a review of the literature and future prospects. | Hafeez, Umbreen ; Cher, Lawrence M |
| 7 | 19-Jun-2018 | Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patients. | Arulananda, Surein; Lynam, James; Sem Liew, Mun; Wada, Morikatsu ; Cher, Lawrence M ; Gan, Hui K |
| 8 | 1-Apr-2011 | Comment on "A report of the natural history of leptomeningeal gliomatosis". | Cher, Lawrence M |
| 9 | 26-Sep-2012 | Commentary: extensive cortical involvement in leptomeningeal carcinomatosis. | Cher, Lawrence M |
| 10 | Oct-2018 | Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial. | Field, Kathryn M; Fitt, Gregory J ; Rosenthal, Mark A; Simes, John; Nowak, Anna K; Barnes, Elizabeth H; Sawkins, Kate; Goh, Christine; Moffat, Bradford A; Salinas, Simon; Cher, Lawrence M ; Wheeler, Helen; Hovey, Elizabeth J; Phal, Pramit M |
| 11 | 16-May-1992 | Comparison of transcranial Doppler with DSA in vertebrobasilar ischaemia. | Cher, Lawrence M ; Chambers, Brian R ; Smidt, V |
| 12 | 22-Aug-2022 | Correction to: Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review. | Gunjur, Ashray ; Balasubramanian, Adithya ; Hafeez, Umbreen ; Menon, Siddharth; Cher, Lawrence M ; Parakh, Sagun ; Gan, Hui K |
| 13 | 1-Mar-2006 | Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. | Cher, Lawrence M ; Murone, Carmel ; Lawrentschuk, Nathan; Ramdave, Shanker; Papenfuss, Anthony; Hannah, Anthony; O'Keefe, Graeme J; Sachinidis, John I; Berlangieri, Salvatore U ; Fabinyi, Gavin C ; Scott, Andrew M |
| 14 | Dec-2018 | Efficacy of Zanubrutinib in the Treatment of Bing-Neel Syndrome. | Wong, Jonathan; Cher, Lawrence M ; Griffiths, James; Cohen, Aileen; Huang, Jane; Wang, Lai; Gregory, Gareth; Opat, Stephen |
| 15 | Jul-2017 | Health-related quality of life outcomes from CABARET: a randomized phase 2 trial of carboplatin and bevacizumab in recurrent glioblastoma | Field, Kathryn M; King, Madeleine T; Simes, John; Espinoza, David; Barnes, Elizabeth H; Sawkins, Kate; Rosenthal, Mark A; Cher, Lawrence M ; Hovey, Elizabeth; Wheeler, Helen; Nowak, Anna K |
| 16 | Jan-2021 | Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma. | Balasubramanian, Adithya ; Gunjur, Ashray ; Hafeez, Umbreen ; Menon, Siddharth; Cher, Lawrence M ; Parakh, Sagun ; Gan, Hui K |
| 17 | 1-Aug-1999 | KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma. | Clarke, K; Basser, R L; Underhill, C; Mitchell, Paul L R ; Bartlett, John; Cher, Lawrence M ; Findlay, M; Dalley, D; Pell, M; Byrne, M; Geldard, H; Hill, J S; Maher, D; Fox, R M; Green, M D; Kaye, A H |
| 18 | 30-Dec-2021 | LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study. | Kong, Benjamin Y; Sim, Hao-Wen; Nowak, Anna K; Yip, Sonia; Barnes, Elizabeth H; Day, Bryan W; Buckland, Michael E; Verhaak, Roel; Johns, Terrance; Robinson, Cleo; Thomas, Marc A; Giardina, Tindaro; Lwin, Zarnie; Scott, Andrew M ; Parkinson, Jonathon; Jeffree, Rosalind; Lourenco, Richard de Abreu; Hovey, Elizabeth J; Cher, Lawrence M ; Kichendasse, Ganessan; Khasraw, Mustafa; Hall, Merryn; Tu, Emily; Amanuel, Benhur; Koh, Eng-Siew; Gan, Hui K |
| 19 | 1-Jun-1993 | Miller Fisher syndrome mimicking stroke in immunosuppressed patient with rheumatoid arthritis responding to plasma exchange. | Cher, Lawrence M ; Merory, J M |
| 20 | 6-Feb-2014 | Mistaken identity: granular cell astrocytoma masquerading as histiocytosis of the central nervous system. | Campbell, Robert N; Liew, Mun Sem; Gan, Hui K ; Cher, Lawrence M |
